Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)
Clinical trial NCT04944368 · COMPLETED
Trial details
- NCT number
- NCT04944368
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-30
- Primary completion
- 2021-07-19
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.